|
Market Closed -
Canadian Securities Exchange
10:37:06 2026-11-13 EST
|
5-day change | 1st Jan Change | ||
| 1.000 CAD | -4.76% |
|
-4.76% | -75.00% |
Company Valuation: ME Therapeutics Holdings Inc.
Data adjusted to current consolidation scope
| Fiscal Period: August | 2024 | 2025 |
|---|---|---|
| Market Cap 1 | 69.27 | 118.4 |
| Change | - | 70.86% |
| Enterprise Value (EV) 1 | 67.77 | 117 |
| Change | - | 72.67% |
| P/E | -51.7x | -93.2x |
| PBR | 46.9x | 78.7x |
| PEG | 0.6x | 4.8x |
| Capitalization / Revenue | - | - |
| EV / Revenue | - | - |
| EV / EBITDA | -49.4x | -94.1x |
| EV / EBIT | -49.4x | -91.7x |
| EV / FCF | - | - |
| FCF Yield | - | - |
| Dividend per Share 2 | - | - |
| Rate of return | - | - |
| EPS 2 | -0.0531 | -0.0429 |
| Distribution rate | - | - |
| Net sales | - | - |
| EBITDA 1 | -1.373 | -1.244 |
| EBIT 1 | -1.373 | -1.276 |
| Net income 1 | -1.295 | -1.193 |
| Net Debt 1 | -1.497 | -1.331 |
| Reference price 2 | 2.750 | 4.000 |
| Nbr of stocks (in thousands) | 25,189 | 29,589 |
| Announcement Date | 11/27/24 | 11/27/25 |
1CAD in Million2CAD
Estimates
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- METX Stock
- Valuation ME Therapeutics Holdings Inc.
Select your edition
All financial news and data tailored to specific country editions
